Are NAD+ Supplements Worth It? What the Human Trials Show
The animal data are exciting. The human trials are smaller, shorter and less consistent than the marketing suggests.
Words by the editors ·
Short answer: nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) reliably raise NAD+ levels in the blood, and the trials so far show them to be well tolerated over weeks to months. What they have not shown is a consistent benefit on the outcomes people buy them for, such as insulin sensitivity, muscle or energy. Whether they are worth it depends on what you expect, and on the fact that the evidence is thinner than the marketing.735
This guide covers oral precursor supplements only. For background on the molecule itself, see our explainer What Is NAD+?
In brief
- NR and NMN raise blood NAD+ in people, and were well tolerated in trials lasting 6 to 12 weeks.12
- NR 2,000 mg/day for 12 weeks did not improve insulin sensitivity or body composition in 40 obese men.3
- NMN improved muscle insulin sensitivity in one 10-week trial of prediabetic women.4
- A 2025 meta-analysis found no significant effect of NMN on muscle mass, grip strength or gait speed in older adults.5
- The FDA does not approve dietary supplements before they are sold.6
What are NAD+ supplements actually made of?
Most "NAD+ supplements" do not contain NAD+. They contain a precursor, a smaller molecule the body converts into NAD+. The two most studied are nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), both related to vitamin B3.74 The rationale is simple: NAD+ levels fall with age in animals, and giving precursors to old or obese rodents improved several markers of metabolic health.8 Whether that carries over to people is the question the human trials try to answer.
Do they raise NAD+ in people?
Yes, on this point the evidence is consistent.
- In an 8-week randomized, placebo-controlled trial of healthy overweight adults, 100, 300 and 1,000 mg of NR raised whole-blood NAD+ by 22%, 51% and 142%, and the rise held for the rest of the study. That trial was funded by the company that sells the NR ingredient, and two authors were its employees.1
- In a crossover trial of healthy middle-aged and older adults, six weeks of NR was well tolerated and increased NAD+ metabolism.7
- In older men given 250 mg of NMN daily for 6 or 12 weeks, blood NAD+ and related metabolites rose significantly, with no significant harmful effects reported.2
Raising a blood level is a laboratory result, not a health benefit. The useful question is whether anything people can feel or measure improves.
Do they improve health outcomes?
The results are mixed, and the better-controlled trials lean toward no clear effect.
| Trial | Who and what | What it found |
|---|---|---|
| Dollerup 20183 | 40 sedentary obese men aged 40 to 70; NR 2,000 mg/day for 12 weeks versus placebo | No improvement in insulin sensitivity, resting energy expenditure or body composition; no serious adverse events |
| Dollerup 20209 | Muscle samples from obese, insulin-resistant men on NR | No change in mitochondrial respiration, content or structure |
| Yoshino 20214 | Postmenopausal women with prediabetes who were overweight or obese; NMN for 10 weeks versus placebo | Muscle insulin sensitivity and insulin signaling increased |
| Igarashi 20222 | Healthy older men; NMN 250 mg/day for 6 or 12 weeks | Nominal improvements in gait speed and left grip strength, which the authors say need validation in larger studies; no effect on body composition |
| Prokopidis 20255 | Meta-analysis of randomized trials in adults with mean age over 60 | NMN had no significant effect on muscle index, grip strength or gait speed; authors concluded evidence does not support use to preserve muscle |
The one positive metabolic result, in prediabetic women, is real and was published in a major journal. It is also a single 10-week trial in a specific group, and it does not tell us what the same supplement would do for a healthy man in his 40s. The two largest bodies of evidence in men, the NR trial in obese men and the pooled analysis in older adults, did not find a benefit.35
Are they safe?
Over the periods studied, yes, with caveats. The trials above reported no serious adverse events attributable to NR or NMN and normal safety blood tests where measured.312 The caveats matter, though. Most trials ran for 6 to 12 weeks. Participants were screened, usually healthy or with one defined condition, and the sample sizes were small. Nobody has data from decades of use, and the trials cannot rule out rare problems or interactions with medicines.
Who regulates these products?
This is the part that is easy to miss. In the United States, the FDA does not approve dietary supplements before they are sold. A manufacturer is responsible for the safety of its product, and the FDA generally does not review the label claims in advance. The agency also does not routinely analyze what is in a bottle.6 Two products that both say "300 mg NMN" can differ in what they actually contain. Look for third-party testing, which is a voluntary step by the maker, and be cautious about any label claiming to treat or reverse aging.
So are NAD+ supplements worth it?
A fair reading of the human evidence is this:
- If you want a proven way to protect muscle, metabolic health and energy, the best-supported options are not supplements. Resistance and aerobic training, enough protein and treating blood pressure and blood sugar have far more evidence behind them. Our feature on exercise, weight and sexual health shows what those habits do in randomized trials.
- If you are curious and willing to accept uncertainty, NR and NMN look low-risk in short trials, but you would be paying for a possibility rather than a demonstrated benefit.
- If you have a medical condition or take prescription drugs, ask a clinician first. The trials mostly excluded people with significant illness.
Be wary of anyone who cites the animal data as if it were proof in people. The strongest findings are in rodents, and the human trials have so far been smaller and shorter than the claims made for them.8
What do people ask before buying?
Questions that come up repeatedly in forums include whether NR or NMN is better, whether any difference can be felt, and why an expensive product did nothing noticeable. The honest answers: no trial has compared the two head to head for outcomes that matter, felt effects are hard to separate from expectation without a placebo group, and the controlled trials above largely did not find a measurable effect on the outcomes they tested.
Questions
Are NAD+ supplements worth it?
Human trials show NR and NMN raise blood NAD+ and are well tolerated over weeks to months, but they have not shown a consistent benefit on insulin sensitivity, muscle or body composition. A 2025 meta-analysis found no significant muscle effects of NMN.
Is NMN or NR better?
No trial has compared them head to head on outcomes that matter. Both raise NAD+ in blood. NMN improved muscle insulin sensitivity in one trial of prediabetic women, while NR did not improve insulin sensitivity in obese men.
Do NAD+ supplements have side effects?
Trials of 6 to 12 weeks reported no serious adverse events from NR or NMN, but long-term safety data are lacking and the FDA does not approve supplements before sale.
Does the FDA approve NAD+ supplements?
No. By law the FDA does not approve dietary supplements before they are marketed, and it does not routinely test their contents.
Also in this edition
Part of our guide: Aging Well: NAD+, Exercise and the Male Body After 40
Notes
- Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep. 2019. PubMed 31278280.
- Igarashi M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. NPJ Aging. 2022. PubMed 35927255.
- Dollerup OL, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. Am J Clin Nutr. 2018. PubMed 29992272.
- Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021. PubMed 33888596.
- Prokopidis K, et al. The effect of nicotinamide mononucleotide and riboside on skeletal muscle mass and function: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2025. PubMed 40275690.
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements.
- Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018. PubMed 29599478.
- Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab. 2018. PubMed 29514064.
- Dollerup OL, et al. Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin-resistant men. J Physiol. 2020. PubMed 31710095.